Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adjunctive Treatment of Major Depressive Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT06340958
What this trial is testing

CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive Disorder

Who this might be right for
Adjunctive Treatment of Major Depressive Disorder (MDD)
Clexio Biosciences Ltd. 99
Large-scale testing (Phase 3)Ended earlyNCT03487198
What this trial is testing

The Safety and Efficacy of Brexpiprazole as Adjunctive Therapy in the Treatment of Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Otsuka Beijing Research Institute 65
Large-scale testing (Phase 3)Looking for participantsNCT06508710
What this trial is testing

Early Effects of Ketamine vs Placebo With Venlafaxine in Severe Depression Patients

Who this might be right for
Major Depressive Episode
Assistance Publique - Hôpitaux de Paris 60
Not applicableActive Not RecruitingNCT07723079
What this trial is testing

Single-case Intervention Study for Visual Screening Assessment for Proof of Concept and Prediction of Clinical Response to Brexiprazole as Adjunctive Treatment in Adults With Major Depressive Disorder.

Who this might be right for
Depression - Major Depressive Disorder
University of Sao Paulo 1
Large-scale testing (Phase 3)Ended earlyNCT01837797
What this trial is testing

Efficacy and Safety of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment

Who this might be right for
Major Depressive Disorder
H. Lundbeck A/S 129
Testing effectiveness (Phase 2)Study completedNCT01437657
What this trial is testing

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Who this might be right for
Major Depressive Disorder
Hoffmann-La Roche 319
Large-scale testing (Phase 3)Study completedNCT03968159
What this trial is testing

Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment

Who this might be right for
Adjunctive Treatment of Major Depressive Disorder
ACADIA Pharmaceuticals Inc. 298
Large-scale testing (Phase 3)Ended earlyNCT01944969
What this trial is testing

Long-term Safety and Tolerability Study of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
H. Lundbeck A/S 26
Testing effectiveness (Phase 2)Looking for participantsNCT07610473
What this trial is testing

Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

Who this might be right for
Major Depressive Disorder (MDD)
Draig Therapeutics Ltd 118
Not applicableStudy completedNCT03679962
What this trial is testing

Triple Chronotherapy in Adolescents

Who this might be right for
Depressive Disorder, MajorBipolar DepressionSuicidal Ideation
Billings Clinic 64
Large-scale testing (Phase 3)Study completedNCT02400346
What this trial is testing

Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment

Who this might be right for
Major Depression Disorder
H. Lundbeck A/S 132
Testing effectiveness (Phase 2)Study completedNCT04103892
What this trial is testing

CLE-100 (Oral Esketamine) in Addition to Standard Antidepressant Drug for Major Depressive Disorder - CLEO Study

Who this might be right for
Adjunctive Treatment of Major Depressive Disorder
Clexio Biosciences Ltd. 146
Large-scale testing (Phase 3)Looking for participantsNCT06966401
What this trial is testing

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive Disorder
Neurocrine Biosciences 850
Not applicableStudy completedNCT01141400
What this trial is testing

The Effect of Patient Cost-Sharing on Antidepressant and Adjunctive Therapy Use

Who this might be right for
Depressive Disorder, Major
Otsuka Pharmaceutical Development & Commercialization, Inc. 48,865
Large-scale testing (Phase 3)Study completedNCT02158533
What this trial is testing

ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-4 Study

Who this might be right for
Major Depressive Disorder
Alkermes, Inc. 385
Early research (Phase 1)Study completedNCT01670279
What this trial is testing

Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 18
Testing effectiveness (Phase 2)Study completedNCT00854100
What this trial is testing

Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Forest Laboratories 231
Not applicableEnrolling By InvitationNCT07146269
What this trial is testing

Virtual Reality-Augmented At-Home tDCS for Major Depression

Who this might be right for
Major Depression ModerateMajor Depression Severe
Technical University of Munich 30
Testing effectiveness (Phase 2)Study completedNCT01469377
What this trial is testing

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Forest Laboratories 819
Large-scale testing (Phase 3)Study completedNCT01727726
What this trial is testing

Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial

Who this might be right for
Depressive DisorderDepressionDepressive Disorder, Major+2 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 2,182
Next Page